Shanghai Bailong Biotechnology Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Shanghai Bailong Biotechnology Co., Ltd. - overview
Established
2019
Location
Shanghai, -, China
Primary Industry
Biotechnology
About
Based in Shanghai, China and founded in 2019, Shanghai Bailong Biotechnology Co. , Ltd. operates as a genetic artificial intelligence technology for innovative drug development, dedicated to artificial intelligence and novel biotechnology-led innovative drug development. The company also established a branch officer in San Francisco Bay Area.
The Company has established a unique pipeline of precision oncology therapies in the area of CDKs and synthetic tumor lethality. The company and its strategic partner Exscientia are developing a series of innovative CDK therapies. The company also has cooperation with WuXi AppTec and Pharmaron and other enterprises. The company will accelerate CDK7 inhibitor program into clinical trials.
The company will also continue to integrate artificial intelligence and structural biology technologies to enhance the company's drug discovery platform.
Current Investors
GT Healthcare Capital Partners, Panacea Venture, Viva Ventures Biotech
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Healthcare IT, Oncology/Cancer Treatment
Website
www.apeiron-bio.com
Verticals
Artificial Intelligence
Company Stage
Series A
Total Amount Raised
Subscriber access only
Shanghai Bailong Biotechnology Co., Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.